NCT03369730View on ClinicalTrials.gov

Reducing the Duration of Untreated Psychosis in the United States

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions
First Episode Psychosis (FEP)At Risk Mental State (ARMS)
Trial Locations (3)

10027

Research Foundation/City University of New York (CUNY) on behalf of CUNY Graduate School, New York

10029

Icahn School of Medicine at Mount Sinai, New York

02215

Trustees of Boston University, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03369730 - Reducing the Duration of Untreated Psychosis in the United States | Biotech Hunter | Biotech Hunter